BioSuspensions is reaching out to Pharma and MedTech companies to help develop a series of SpheruLUGOL™ medical devices. The collaborative partnerships will combine BioSuspensions’ innovative …
Read more
BioSuspensions is reaching out to Pharma and MedTech companies to help develop a series of SpheruLUGOL™ medical devices. The collaborative partnerships will combine BioSuspensions’ innovative …
Read more
BioSuspensions has entered into a collaborative MSc project with the University of Nottingham. The project will be based at the Sutton Bonington Campus, exploring the …
Read more
BioSuspensions has been awarded a £50,000 grant from Innovate UK to advance research and development of its innovative structured suspension system, SpheruLUGOL™ . This cutting-edge …
Read more
BioSuspensions is among the finalists to present their technology at the Royal Society of Chemistry’s flagship event, “Chemistry Means Business” on 15th October at QEII …
Read more
Prof Paul J Smith invited to present BioSuspensions novel SpheruliTEK™ drug formulation technology to academic and industry leaders at the new Life Sciences Hub Wales …
Read more
BioSuspensions has signed a MSc Project collaboration with the Centre for Macromolecular Hydrodynamics at the University of Nottingham. The project will run over three months …
Read more
BioSuspensions has signed a collaboration agreement with Bradford University, Shanghai University of Traditional Chinese Medicine, and Changzhou Yabang Pharmaceuticals Co. Ltd through the Science Bridges …
Read more
BioSuspensions is delighted to announce the winning of a Pathfinder award from the East Midlands Development Agency and the East Midlands Healthcare Innovation Network. The …
Read more
BioSuspensions is pleased to announce that it has secured an Innovation Voucher to allow an exploratory project to proceed between BioSuspensions and Prof Clive Roberts …
Read more
BioSuspensions will be accompanying BioStatus Limited to the SBS2009 conference in Lille, France. This key drug discovery conference is an important first exhibition for BioSuspensions. …
Read more
BioSuspensions is actively seeking investment partners to exemplify its core technology across a wide range of drug treatments.
BioSuspensions is currently seeking partners to evaluate its formulation technologies. If you have an insoluble drug requiring a liquid formulation, we would like to hear from you.